What drives one of the most influential people in the world of cryptocurrency when he invests millions in biotechnology? Changpeng Zhao (CZ), former CEO of Binance, transferred $10 million in BNB to Vitalik Buterin, co-founder of Ethereum, to support open-source projects in biotech.
Buterin, known for his commitment to scientific research, actively finances the development of vaccines, the study of longevity, and technologies for the early detection of viruses. Although CZ has not disclosed specific projects, one thing is clear: his investments are part of a larger strategy.
Investment philosophy: not profit, but impact
Jane He, managing partner of the fund, revealed Zhao's motives in her post:
"For him, this is not a pursuit of the next sensation. It is a challenge to a system that too often prioritizes profit over people. He has witnessed a handful of giants shape the entire industry, dictating not only the pace of innovation but also who gets access to medical care and who gets forgotten."
According to her, CZ sees biotechnology as an opportunity to change the game — to support those with groundbreaking ideas but no resources to implement them.
Charity as part of the strategy
In addition to investments in biotech, Zhao has made several private donations to other charitable initiatives. His approach is not just financial support, but creating sustainable solutions to global problems.
Buterin highly valued CZ's contribution:
"Thank you for your support in the mission to preserve the health and safety of humanity from airborne diseases."
Why biotechnology
The crypto world's interest in biotech is not accidental. Here are a few facts:
Decentralization of science — blockchain allows for the creation of open databases for research, accelerating developments.
Longevity — it is projected that by 2030, the anti-aging technology market will reach $64 billion.
Early diagnosis — new methods of virus detection could save millions of lives.
